These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10737737)

  • 1. Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogens.
    Or YS; Clark RF; Wang S; Chu DT; Nilius AM; Flamm RK; Mitten M; Ewing P; Alder J; Ma Z
    J Med Chem; 2000 Mar; 43(6):1045-9. PubMed ID: 10737737
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens.
    Agouridas C; Denis A; Auger JM; Benedetti Y; Bonnefoy A; Bretin F; Chantot JF; Dussarat A; Fromentin C; D'Ambrières SG; Lachaud S; Laurin P; Le Martret O; Loyau V; Tessot N
    J Med Chem; 1998 Oct; 41(21):4080-100. PubMed ID: 9767644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antibacterial activity of 6-O-(heteroaryl-isoxazolyl)propynyl 2-fluoro ketolides.
    Sugimoto T; Shimazaki Y; Manaka A; Tanikawa T; Suzuki K; Nanaumi K; Kaneda Y; Yamasaki Y; Sugiyama H
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5739-43. PubMed ID: 22858102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antibacterial activity of 6-O-arylpropargyl-9-oxime-11,12-carbamate ketolides.
    Beebe X; Yang F; Bui MH; Mitten MJ; Ma Z; Nilius AM; Djuric SW
    Bioorg Med Chem Lett; 2004 May; 14(10):2417-21. PubMed ID: 15109624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antibacterial activity of a novel series of acylides: 3-O-(3-pyridyl)acetylerythromycin A derivatives.
    Tanikawa T; Asaka T; Kashimura M; Suzuki K; Sugiyama H; Sato M; Kameo K; Morimoto S; Nishida A
    J Med Chem; 2003 Jun; 46(13):2706-15. PubMed ID: 12801234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis.
    Schmitz FJ; Schwarz S; Milatovic D; Verhoef J; Fluit AC
    J Antimicrob Chemother; 2002 Jul; 50(1):145-8. PubMed ID: 12096026
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens.
    Ma Z; Clark RF; Brazzale A; Wang S; Rupp MJ; Li L; Griesgraber G; Zhang S; Yong H; Phan LT; Nemoto PA; Chu DT; Plattner JJ; Zhang X; Zhong P; Cao Z; Nilius AM; Shortridge VD; Flamm R; Mitten M; Meulbroek J; Ewing P; Alder J; Or YS
    J Med Chem; 2001 Nov; 44(24):4137-56. PubMed ID: 11708916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.
    Drago L; De Vecchi E; Nicola L; Colombo A; Gismondo MR
    J Antimicrob Chemother; 2004 Aug; 54(2):542-5. PubMed ID: 15215227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacies of ABT-773, a new ketolide, against experimental bacterial infections.
    Mitten MJ; Meulbroek J; Nukkala M; Paige L; Jarvis K; Oleksijew A; Tovcimak A; Hernandez L; Alder JD; Ewing P; Or YS; Ma Z; Nilius AM; Mollison K; Flamm RK
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2585-93. PubMed ID: 11502533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of novel alkylides: 3-O-arylalkyl clarithromycin derivatives with improved antibacterial activities.
    Liang JH; Li XL; Wang H; An K; Wang YY; Xu YC; Yao GW
    Eur J Med Chem; 2012 Mar; 49():289-303. PubMed ID: 22301216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antibacterial activity of 6-O-arylbutynyl ketolides with improved activity against some key erythromycin-resistant pathogens.
    Keyes RF; Carter JJ; Englund EE; Daly MM; Stone GG; Nilius AM; Ma Z
    J Med Chem; 2003 May; 46(10):1795-8. PubMed ID: 12723941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin.
    Felmingham D
    J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative activity of telithromycin against typical community-acquired respiratory pathogens.
    Buxbaum A; Forsthuber S; Graninger W; Georgopoulos A
    J Antimicrob Chemother; 2003 Sep; 52(3):371-4. PubMed ID: 12888585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide resistance in Streptococci and Haemophilus influenzae.
    Bozdogan B; Appelbaum PC
    Clin Lab Med; 2004 Jun; 24(2):455-75. PubMed ID: 15177849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antibacterial activity of novel ketolides with 11,12-quinoylalkyl side chains.
    Zhao ZH; Zhang XX; Jin LL; Yang S; Lei PS
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2358-2363. PubMed ID: 29937059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antibacterial activity of novel C12 vinyl ketolides.
    Burger MT; Lin X; Chu DT; Hiebert C; Rico AC; Seid M; Carroll GL; Barker L; Huh K; Langhorne M; Shawar R; Kidney J; Young K; Anderson S; Desai MC; Plattner JJ
    J Med Chem; 2006 Mar; 49(5):1730-43. PubMed ID: 16509588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of telithromycin (HMR 3647) in relation to in vitro simulated human plasma kinetics.
    Bonnefoy A; Le Priol P
    J Antimicrob Chemother; 2001 Apr; 47(4):471-3. PubMed ID: 11266424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will resistance to ketolides develop in Streptococcus pneumoniae?
    Leclercq R
    J Infect; 2002 Feb; 44 Suppl A():11-6. PubMed ID: 12150490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new series of macrolide derivatives with 4''-O-saccharide substituents.
    Xu P; Chen XZ; Liu L; Jin ZP; Lei PS
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5527-31. PubMed ID: 20716487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
    Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
    J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.